These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 8531220

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
    Date I, Asari S, Nishimoto A, Felten DL.
    No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347
    [Abstract] [Full Text] [Related]

  • 3. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS, Schneider JS.
    Brain Res; 1998 Jan 01; 779(1-2):226-30. PubMed ID: 9473679
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY, Park HJ, Ahn YH, Lee PH.
    J Neurochem; 2009 Nov 01; 111(4):1042-50. PubMed ID: 19765187
    [Abstract] [Full Text] [Related]

  • 5. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK, Keyghobadi M, Moore C, Meshul CK.
    Neuroscience; 2005 Nov 01; 136(1):333-41. PubMed ID: 16198485
    [Abstract] [Full Text] [Related]

  • 6. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y, Watanabe A, Mori A, Koga N.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):660-3. PubMed ID: 9703982
    [Abstract] [Full Text] [Related]

  • 7. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
    Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, Agid Y.
    Ann Neurol; 1994 Aug 30; 36(2):206-14. PubMed ID: 7914399
    [Abstract] [Full Text] [Related]

  • 8. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
    Schneider JS.
    J Neurosci Res; 1992 Jan 30; 31(1):112-9. PubMed ID: 1613817
    [Abstract] [Full Text] [Related]

  • 9. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 10. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M, Mariani AP, Neff NH.
    Brain Res; 1989 Apr 10; 484(1-2):297-303. PubMed ID: 2565752
    [Abstract] [Full Text] [Related]

  • 11. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK, Keyghobadi M, Moore C, Menashe RA, Meshul CK.
    Synapse; 2005 Aug 10; 57(2):100-12. PubMed ID: 15906381
    [Abstract] [Full Text] [Related]

  • 12. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.
    Date I, Felten SY, Felten DL.
    Neurosci Lett; 1989 Dec 04; 106(3):282-6. PubMed ID: 2601883
    [Abstract] [Full Text] [Related]

  • 13. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 04; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 14. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J, Wang YY, Liu L, Wang QD, Yuan ZY, Zhang ZX, Gu P, Wang MW.
    Neurosci Lett; 2008 Dec 26; 448(2):184-8. PubMed ID: 18977411
    [Abstract] [Full Text] [Related]

  • 15. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 26; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW, Bradbury KA, Schneider JS.
    Eur J Neurosci; 2006 Dec 26; 24(11):3174-82. PubMed ID: 17156378
    [Abstract] [Full Text] [Related]

  • 17. Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.
    Rothblat DS, Schneider JS.
    Ann N Y Acad Sci; 1998 Jun 19; 845():274-7. PubMed ID: 9668361
    [Abstract] [Full Text] [Related]

  • 18. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb 19; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S, Wirz SA, Barr AM, Conti B, Bartfai T, Shibasaki T.
    Neuroscience; 2004 Feb 19; 128(2):451-8. PubMed ID: 15350655
    [Abstract] [Full Text] [Related]

  • 20. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
    Pope-Coleman A, Tinker JP, Schneider JS.
    Synapse; 2000 May 19; 36(2):120-8. PubMed ID: 10767059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.